Does LISOCABTAGENE MARALEUCEL Cause Encephalopathy? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Encephalopathy have been filed in association with LISOCABTAGENE MARALEUCEL (BREYANZI). This represents 2.3% of all adverse event reports for LISOCABTAGENE MARALEUCEL.
17
Reports of Encephalopathy with LISOCABTAGENE MARALEUCEL
2.3%
of all LISOCABTAGENE MARALEUCEL reports
3
Deaths
10
Hospitalizations
How Dangerous Is Encephalopathy From LISOCABTAGENE MARALEUCEL?
Of the 17 reports, 3 (17.6%) resulted in death, 10 (58.8%) required hospitalization, and 3 (17.6%) were considered life-threatening.
Is Encephalopathy Listed in the Official Label?
Yes, Encephalopathy is listed as a known adverse reaction in the official FDA drug label for LISOCABTAGENE MARALEUCEL.
What Other Side Effects Does LISOCABTAGENE MARALEUCEL Cause?
Cytokine release syndrome (315)
Immune effector cell-associated neurotoxicity syndrome (129)
Neurotoxicity (101)
Pyrexia (47)
Fatigue (38)
Hypotension (38)
Febrile neutropenia (28)
Confusional state (27)
Death (25)
Lymphocyte adoptive therapy (25)
What Other Drugs Cause Encephalopathy?
BACLOFEN (845)
METHOTREXATE (775)
ACETAMINOPHEN (608)
IFOSFAMIDE (585)
CYCLOPHOSPHAMIDE (552)
TACROLIMUS (523)
PREDNISONE (489)
DEXAMETHASONE (428)
METFORMIN (418)
ETOPOSIDE (404)
Which LISOCABTAGENE MARALEUCEL Alternatives Have Lower Encephalopathy Risk?
LISOCABTAGENE MARALEUCEL vs LITHIUM
LISOCABTAGENE MARALEUCEL vs LIXISENATIDE
LISOCABTAGENE MARALEUCEL vs LOBAPLATIN
LISOCABTAGENE MARALEUCEL vs LOFEXIDINE
LISOCABTAGENE MARALEUCEL vs LOMITAPIDE